← Back to Search

PrEP Uptake Intervention for HIV Prevention in Latino MSM

N/A
Recruiting
Led By Ronald A Brooks, PhD
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Man who has had sex with other men in the past 24 months
Not currently using PrEP for HIV prevention
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 3-month follow-up
Awards & highlights

Study Summary

This trialwill test a special program to help Latino MSM reduce their risk of HIV by using pre-exposure prophylaxis (PrEP).

Who is the study for?
This trial is for Latino men who have sex with men, are at least 18 years old, and identify as male from birth. They should not be currently using PrEP for HIV prevention and must either be HIV-negative or unaware of their HIV status.Check my eligibility
What is being tested?
The study is testing a culturally tailored intervention called 'Estoy PrEParado/I am PrEPared' against usual care to see if it helps increase the use of pre-exposure prophylaxis (PrEP) among at-risk Latino men who have sex with men.See study design
What are the potential side effects?
Since this trial focuses on behavioral intervention rather than medication, there may not be direct side effects like those seen with drugs. However, participants might experience stress or discomfort discussing personal behaviors related to HIV prevention.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a man who has had sexual relations with another man in the last 2 years.
Select...
I am not using HIV prevention medication.
Select...
I was assigned male at birth.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 3-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 3-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
PrEP adherence single measure
PrEP adherence urine sample
PrEP initiation
Secondary outcome measures
Changes in Readiness to Adopt PrEP

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Latino MSM PrEP interventionExperimental Treatment1 Intervention
The Latino MSM PrEP intervention consists of 4 small group sessions with concurrent peer navigation and counseling.
Group II: Control conditionActive Control2 Interventions
The control condition consists of usual care at the study site (i.e., referrals to PrEP services).

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,525 Previous Clinical Trials
10,279,658 Total Patients Enrolled
Bienestar Human Services, Inc.OTHER
3 Previous Clinical Trials
599 Total Patients Enrolled
Ronald A Brooks, PhDPrincipal InvestigatorUniversity of California, Los Angeles

Media Library

Estoy PrEParado/ I am PrEPared intervention Clinical Trial Eligibility Overview. Trial Name: NCT05434390 — N/A
HIV/AIDS Research Study Groups: Latino MSM PrEP intervention, Control condition
HIV/AIDS Clinical Trial 2023: Estoy PrEParado/ I am PrEPared intervention Highlights & Side Effects. Trial Name: NCT05434390 — N/A
Estoy PrEParado/ I am PrEPared intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05434390 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has recruitment for this trial recently opened?

"Affirmative. Clinicaltrials.gov confirms that this experiment, which was first posted on October 3rd 2022 and most recently updated November 3rd 2022, is enrolling participants. 80 humans must be recruited from a single research centre."

Answered by AI

How many patients have enrolled in this clinical trial thus far?

"Affirmative. According to ClinicalTrials.gov, this clinical trial is currently accepting enrolment and was last updated on the 3rd of November 2022; it initially went public on the 3rd of October 2022. 80 individuals from a single location are necessary for successful completion."

Answered by AI
~33 spots leftby Mar 2025